chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 7 year old white male with no medical history who on 2/27/98 was vaccinated SQ in the right arm with the first dose of varicella virus vaccine live (lot # 62443/1106E). Concomitant vaccinations on that same day included the fourth dose of IM diphtheria toxoid (+) pertussis vaccine (+) tetanus toxoid in the left arm (lot # 7091715) and the third dose of PO poliovirus vaccine inactivated (lot # 0907380). There was no illness at the time of vaccination. The physician reported that, on the morning of 2/6/04, the patient was diagnosed with chicken pox characterized by approximately 20 lesions (vesicles with a red base) mainly on his trunk and extremities. The patient was noted to be afebrile and had no cough, itching, or any other symptoms at that time. Unspecified medical attention was sought, but no prescription drug was required for treatment. In February 2004, the patient's chicken pox resolved. Additional information is not expected.
Approximately 10 hrs after receiving second dose of Moderna,   fever of 102, shaking chills, headache, lightheaded,  joint pain,  body aches,  extreme fatigue, loss of  appetite.  lasted for the next 24 hrs. Took Tylenol, fluids,  Day 2 after vaccine-  temp - 99.5.  Fatigue and body aches continue
injection site is hard; injection site is red; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE INDURATION (injection site is hard) and VACCINATION SITE ERYTHEMA (injection site is red) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced VACCINATION SITE INDURATION (injection site is hard) and VACCINATION SITE ERYTHEMA (injection site is red). At the time of the report, VACCINATION SITE INDURATION (injection site is hard) and VACCINATION SITE ERYTHEMA (injection site is red) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment information was provided.
second dose muscle pain; second dose tiredness; second dose chills; muscle pain; Tiredness; Chills; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 09:30 (Lot number: EW0150, Expiration Date: 31Jul2021) at the age of 29 years as dose 1, single and administered in arm left, administration date 29Apr2021 09:30 (Lot number: EW0172) as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: MYALGIA (non-serious) with onset 07Apr2021, outcome "recovered" (08Apr2021), described as "muscle pain"; FATIGUE (non-serious) with onset 07Apr2021, outcome "recovered" (08Apr2021), described as "Tiredness"; CHILLS (non-serious) with onset 07Apr2021, outcome "recovered" (08Apr2021), described as "Chills"; MYALGIA (non-serious) with onset 29Apr2021, outcome "recovered" (30Apr2021), described as "second dose muscle pain"; FATIGUE (non-serious) with onset 29Apr2021, outcome "recovered" (30Apr2021), described as "second dose tiredness"; CHILLS (non-serious) with onset 29Apr2021, outcome "recovered" (30Apr2021), described as "second dose chills". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: No prior vaccinations (within 4 weeks). No family history. The patient was taking Pfizer COVID 19 vaccine as mother was a nurse kept pestering them. Stated he and his fiancee both got the vaccination on 29Apr2021 and he had symptoms for a day but his fiancee has showed symptoms everyday. She had to take four days off work. Besides the usual swelling and redness at the injection site she has had difficulty breathing and a fast heart beat. Stated he needed to know exactly what to do to help her. Advised caller may provide product specific information but to contact his HCP for medical advice. Caller clarified they both received the first dose 22 days prior on 7Apr2021 at 09:30AM in left arm; then received the second dose on 29Apr2021 at 09:30AM in the left arm. Reported both times he had the same effects. Muscle pain - started two hours before bed and woke up the next day with all of it. Tiredness - same as the muscle pain. Little bit of chills - chills for about two hours at night both nights. Mentioned he did not sleep that well and he noticed the chills more often. Added that is it, nothing much. This happened again the same way, same time and ended the same after the second dose and he was now fully recovered. Vaccine was not Administered at Facility.   No follow-up attempts are possible. No further information is expected.
Recurrent cough, difficulty taking a deep breath, chest tightness, wheezing periodic, continuous mucus production worse in mornings productive cough for over past three months starting Two weeks after the second dose. Persistently suppressed pulmonary function tests With only minimal improvement with bronchodilators, insulation treatments, and nasal steroids. Patient states that this is not has not been a problem prior to the vaccine series.
The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned,  took the following steps: ? Covid-19 Response Unit Pharmacists contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  o A county medical director was contacted and based on this information from Moderna, no re-vaccination is needed.
Child vaccine that may have had temperature excursion (Data Logger Failure) with stable Fridge temps Before & After. DOH determined the vaccine to Be At Risk & Advised Reporting & revaccination Child Had no ill Effects thus FAR
No adverse effects; patients received improperly stored vaccines; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information regarding the patient's medical history, concurrent conditions or concomitant medications was provided. On 08-FEB-2019, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) 0,5 milliliter injection, intramuscularly, lot # N007750, expiration date 29-NOV-2019 (dose, and anatomical location were not reported) for prophylaxis.  The reported vaccines were exposed to the temperature of 35.4 degrees Fahrenheit for 32 hours and 30 minutes. No previous temperature excursions were reported. A digital data logger was involved. No adverse event was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1905USA014098: US-009507513-1905USA014099: US-009507513-1905USA014106: US-009507513-1905USA014101: US-009507513-1905USA014102: US-009507513-1905USA014103: US-009507513-1905USA014104: US-009507513-1905USA008566: US-009507513-1905USA014097: US-009507513-1905USA014096: US-009507513-1905USA014100:
pt recv vax 23MAR98;pt dx Lupus APR98, devel sores in both legs which made pt bedridden, now pt disabled;pt was perfectly fine until got the vax;
This is a spontaneous report from a contactable consumer (patient). A 61-year-old (non-pregnant) female patient received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine; solution for injection, batch/lot#, expiration date not reported), at age 61, via an unspecified route of administration, left arm, on Aug 8, 2021, 13:00, single dose, for COVID-19 immunization at a pharmacy or drug store. Medical history included heart stents. The patient has no known allergies. The patient's concomitant medications not reported. Prior to vaccination, patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine and no other medications administered within two weeks. The patient has not tested with COVID-19 since the vaccination. The patient was extremely tired and weak, low-grade fever, cough, short-of-breath, nauseated and diarrhea on Aug 8, 2021; 13:00. No treatment received for the events, with outcome of recovering. The lot number for BNT162B2: not provided (will be requested during follow-up).
Patient started to get shaky and dizzy and complaining of being clod and sick inside about 5 to 10 minutes after taking vaccine
Pt reports coughing spasms, chills and fatigue.  She says the symptoms are exactly like the symptoms she had when she had Covid.
The adverse event was that I got Covid. Recovered in a week to 10 days No difficulties with pregnancy Gave Birth 03/09/2022 Baby's weigh 7lbs 10oz. Normal birth, no issues
Upon awakening the morning of April 18, the day after the 2nd dose, I had severe muscle pain between my left shoulder blade and spine.  The pain occasionally went away but always came back.  Around April 22 or 23 the pain moved down to the underneath side of my left  tricep just above the elbow, but still would occur at the original site on my back. By the 25th or 26th the pain had started occuring as well in my left pectoral muscle right at the breastbone.  Now the pain migrates around all 3 areas and can occupy one or all sites simultaneously.  The pain has subsided somewhat by   the time I saw my primary.  He prescribed icing the back 3 times a day and referred me to phys therapy.    Phys therapist gave me stretching exercises
01/19/2020  Has shingles and it starts from his left ear in the back then down his neck in the back and half way  down his back and up his left arm at the top. then it circles around to his chest and up to his nipple and half his breast area. went to and gave him something for the shingles.
Patient stated her arm has progressively became more sore, achy and tender to the touch as the days go by. She has been waking up each night in pain and is alternating MOTRIN and TYLENOL. She can't lay on it or move it well. Her glands below her ear on that side are swollen.
Per Dr. request was here today. Localized reaction and noticed on R deltoid 98 x 6mm and redness. Per patient Hx this is not the first time, but not recall if is the first time with same vaccine or combinations.
Very early in the morning on December 31st, I began to have serious itching at the injection site. There was no rash or anything you could see on the skin, it was a very deep itch. In the morning my arm was sore again just like it had been right after the injection the week before. The area began to get swollen and red. Today it is even more swollen and red and warm. It is sore and itchy as well.
Pt c/o "dizziness" 20 mins after administration. VSS. Pt monitored for total of 40 mins. Discharged home.
This case was reported and described the occurrence of uveitis in a 45-year-old female subject who was vaccinated with Hepatitis B vaccine, (manufacture unspecified). Concurrent medications included Fluoxetine. On an unspecified date the subject received 1st dose of Hepatitis B vaccine (unknown). Two days after vaccination with Hepatitis B vaccine, the subject experienced uveitis, fatigue and fever. This case was assessed as medically serious by GSK. This is one of the 32 reported cases (B0662264A till B0662297A) of uveitis which occurred after hepatitis b vaccine between 1982 and 2009. It appeared that all subject's recovered, although the treatment for uveitis was not reported. The uveitis occurred in average of 3 days after vaccination in patients without other risk factors or disease that could cause uveitis. This could be consistent with immune complex deposition or nonspecific activation from vaccine adjuvants. Although there was a debate that uveitis occurs because of hepatitis B infection there was evidence that immune complexes deposition diseases such as glomerulonephritis and cryoglobulinemia occurred during chronic hepatitis B infection. Furthermore it was possible the surface antigen of the vaccine and the hepatitis B antibodies of the immune response after vaccination formed immune complexes, which initiated the ocular response of uveitis.
Large red rash on chest and back with bumpy lesion turned to bruise. Next day painful lump at lesion spot.
Fever, chills, loss of appetite, diarrhea for 30 hours. Soreness in left arm still there
Medication Stored Outside of Recommended Temperature Excursion Ranges Was Administered to Patient (; Initial Report Received on 20-Dec-2019  A Nurse called and reported that a 48-year-old female patient received HEPLISAV-B that was stored outside of the recommended temperature range.  The patient has had a blood pressure of 131/78 at the time of vaccination with HEPLISAV-B.    The patient had no medical history and medication history was unknown.  On 19-Dec-2019, the patient was vaccinated with her second dose of HEPLISAV-B (Lot # 933842, expiration 30 May 2021, Box Serial # 277427890985) that was determined to have been stored outside of the recommended range (maximum 16 degrees Celsius for 65 hours) for a temperature excursion.     At the time of the report, the patient had not been informed and there were no adverse reactions reported.   No additional information was provided.    Company comment: The company assessed the event of product storage error as non-serious. The event of product storage error is unlisted per HEPLISAV-B USPI.; Sender's Comments: The company assessed the event of product storage error as non-serious. The event of product storage error is unlisted per HEPLISAV-B USPI and IB.
came down with severe flu; Initial information received on 02-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves a patient of unknown demographics who while receiving vaccine INFLUENZA VACCINE, always immediately came down with severe flu.  The patient's past, medical treatment(s), vaccination(s) and family history were not provided. It was unknown if the patient had any medical history, concomitant disease or risk factor.  On an unknown date, the patient received an unknown dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (formulation, strength, route: unknown) lot number not reported via unknown route in unknown administration site for flu.  On an unknown date the patient came down with severe flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It was unknown if there were lab data/results available. It was unknown if the company suspect product inappropriately used as per local Marketing authorization  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (came down with severe flu).  At time of reporting, the outcome was Unknown for the event came down with severe flu.
Increased hunger; This spontaneous case was reported by a consumer and describes the occurrence of HUNGER (Increased hunger) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination.     The patient's past medical history included Blood pressure.   On 01-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced HUNGER (Increased hunger). At the time of the report, HUNGER (Increased hunger) outcome was unknown. Not Provided
Pfizer vaccine was administered outside of clinic- reported by patient- ? NO LOT NUMBER WERE SUPPLIED ------------------------------------------------------------------------------------------------------------------------------------ ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/4/2023 ACUTE HYPOXEMIC RESPIRATORY FAILURE
side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effects) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.            No concomitant medications reported by reporter No treatment medications provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-Jan-2022: No new information received
Rash started the evening of 1/31/14. Pt started with rash to the face (forehead, sides of eyes). She had rash on stomach, knees and lower back. The marks directly far apart from one another. Pt. has had 2 Varicella vaccines 1/2008, 6/2011.
Pt also had received covid vaccine at~934am. Hx of HTN and DM (nonadherent to BP meds). then around 9:57am, pt c/o be Vomiting, Diaphoresis, HA, Chest pain 3/10. Pt was offered by staff to call ED but pt decline. Pt will go to ED with family member for further evaluation.  During ED visit, it was found by provider that patient has been out of her blood pressure medications for over a year. Pt was prescribed amlodipine and recommended for pt to follow-up with PCP at discharge
I received the FLUZONE QUAD wyr 2016-17 inj from the pharmacy. Since then the injection site has a big red mark about 1/2 a fist size, swelling,pain and severe headaches. I'm sleepy all the time, loss of appetite, diarrhea, and ikky tummy. Its been 3 days and its not getting better..ive gotten the flu shot every year..the only difference was this time I got the shot early instead of waiting like i usually do. Was this a bad batch or what?
This is a spontaneous report from a contactable pharmacist. A patient of unspecified age, ethnicity and gender received PREVNAR, via an unspecified route of administration, on an unspecified date as a single dose. Medical history and concomitant medications were not reported. The patient developed a rash and redness on the site on an unspecified date with outcome of unknown. Clinical description was reported as follows: pharmacist reported that they gave one of their patients a PREVNAR injection on 07Oct (year unspecified) and they had developed a rash and redness on the site of injection. Causality was reported as follows Pharmacist mentioned that "it was because of other injections patient got there. So, it was kind of other injection's site." So, he did not think that there was any causality related to the events for PREVNAR. Pharmacist reported that there was not a reasonable possibility this events were related to the suspect product. Follow-up (19Nov2015): Follow-up attempts completed. No further information expected.
shoulder is killing her, the muscle around the whole shoulder is sore.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 14Nov2022 as dose 3 (booster), single (Lot number: GJ2524, Expiration Date: 30Jun2023) at the age of 62 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "shoulder where she had the replacement" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: BNT162b2 (Lot: FJ6369 in right arm as dose 1, single), administration date: 14Feb2022, when the patient was 61-year-old, for COVID-19 Immunization, reaction(s): "no adverse event"; BNT162b2 (Lot: FK9893 in right arm as dose 2, single), administration date: 07Mar2022, when the patient was 61-year-old, for COVID-19 Immunization, reaction(s): "no adverse event". The following information was reported: MYALGIA (non-serious) with onset 15Nov2022, outcome "not recovered", described as "shoulder is killing her, the muscle around the whole shoulder is sore.".  Additional information: Patient was calling about the Pfizer Covid-19 Bivalent vaccine for 12 years and up. She just had the shot yesterday in the left arm. She had a shoulder replacement and they gave her the vaccine in the shoulder where she had the replacement. Her shoulder is killing her today. The muscle around the whole shoulder is sore. She did not realize that she gave them at that arm and was not thinking that it was the shoulder where she had the replacement. Patient woke up with the pain today (day of report). It was reported that she had no problems with the other 2 injections. Patient vaccination facility type was pharmacy. Patient has no prior vaccination. No relevant family medical history to adverse event. Patient was asking if is it okay that they gave her the shot in the replacement shoulder and she was having pain.
ROTATEQ given after 14 weeks-6 days. In 15th week. No reaction - nothing but given 4 days late.
I had a headache like 30 minutes afterwards. I had body aches and fatigue. On Saturday I started having chest pain and trouble breathing. I went to urgent care on Sunday. They did an EKG, blood work, CTA of lungs. The EKG was a little bit abnormal, blood work- dimer was elevated, CTA was normal. They prescribed Ibuprofen and Colchicine. I saw a cardiologist on Wednesday. I still have some chest pain from time to time. My heart rate is a little bit elevated from its baseline. They did an echocardiogram on Wednesday and it was normal.
received the first dose of Shingrix / second dose six weeks after that.; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too short in a 63-year-old patient who received Herpes zoster (Shingrix) (batch number DS754, expiry date 18th December 2022) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received 2nd dose of Shingrix, less than the recommended interval, which led to shortening of vaccination schedule. The patient received 2nd dose 6 weeks after the 1st dose. The reporter consented to follow up.
pt is hospitalized 2/21/21; current LP is pending; pt has fevers, occipital pain, malaise, neck pain, vomiting; elevated ESR & CRP; MRI & Ct Scan are negative.  infectious disease physician Dr.'s differential diagnosis is: Meningoencephalitis (LP performed and is pending results)   Vaccine
18 month old baby given "KINRIX", which is for ages 4 to 6 years. Child did not have any reactions to the vaccine, but the wrong vaccine was given.
Temp 103 F, severe headache, dizziness, nausea, extreme thirst, blurry vision, poor appetite - treatment with Tylenol extended release q6h, plenty of water, rest. This all started at about
Miscarriage.  Pregnancy developed to 5.5 weeks only, discovered during 6.5 week ultrasound 1 week later. (First day of last period March 1, 2021)
Once I received the dose my elbow began to hurt. The feeling later continued to my left hand. The elbow pain now feels of burning and stiff. My left hand has swelled and feeling of joint pain. My left hand also is cold to touch. No discoloration.